| Rank | Ticker | Exchange | Price | Market Cap | 52W High | 52W Low | Analyst Rating |
|---|---|---|---|---|---|---|---|
#1 | COST | Nasdaq | $854.96 | $431.1B | $1,078.24 | $844.06 | Buy |
#2 | TMUS | Nasdaq | $197.20 | $236.3B | $276.49 | $194.01 | Buy |
#3 | AMT | Nasdaq | $172.20 | $84.8B | $234.33 | $171.95 | Buy |
#4 | MSI | Nasdaq | $369.97 | $61.3B | $492.22 | $359.36 | Buy |
#5 | TRI | Nasdaq | $131.98 | $59.5B | $218.42 | $128.16 | Buy |
#6 | EOG | Nasdaq | $101.70 | $58.0B | $138.18 | $101.59 | Buy |
#7 | ROP | Nasdaq | $446.02 | $48.0B | $595.17 | $435.42 | Buy |
#8 | PSA | Nasdaq | $259.47 | $46.4B | $322.49 | $256.60 | Buy |
#9 | LNG | Nasdaq | $189.43 | $46.4B | $257.65 | $186.20 | Strong Buy |
#10 | JD | Nasdaq | $28.80 | $42.3B | $46.45 | $28.21 | Buy |
#11 | VICI | Nasdaq | $27.68 | $32.4B | $34.03 | $27.63 | Buy |
#12 | TW | Nasdaq | $104.58 | $22.9B | $152.65 | $101.71 | Buy |
#13 | SBAC | Nasdaq | $189.73 | $20.2B | $245.16 | $185.13 | Buy |
#14 | CDW | Nasdaq | $139.29 | $18.9B | $222.92 | $135.63 | Buy |
#15 | DOCS | Nasdaq | $43.80 | $12.3B | $85.21 | $43.29 | Buy |
#16 | LW | Nasdaq | $44.13 | $8.3B | $68.79 | $43.71 | Buy |
#17 | KBR | Nasdaq | $40.42 | $5.5B | $60.98 | $39.61 | Buy |
#18 | ALH | Nasdaq | $20.38 | $4.4B | $27.48 | $20.11 | Strong Buy |
#19 | VVV | Nasdaq | $29.54 | $3.9B | $41.33 | $29.29 | Buy |
#20 | TLX | Nasdaq | $7.82 | $3.3B | $30.36 | $7.72 | Strong Buy |
#21 | CNK | Nasdaq | $22.16 | $3.3B | $34.01 | $21.60 | Strong Buy |
#22 | FCPT | Nasdaq | $23.30 | $2.5B | $29.81 | $22.80 | Buy |
#23 | MNR | Nasdaq | $11.17 | $2.1B | $19.00 | $10.93 | Strong Buy |
#24 | CRTO | Nasdaq | $19.45 | $1.1B | $47.27 | $19.00 | Buy |
#25 | FVRR | Nasdaq | $19.86 | $754.2M | $35.45 | $19.36 | Strong Buy |
#26 | SABR | Nasdaq | $1.50 | $627.9M | $4.63 | $1.46 | Buy |
#27 | PTLO | Nasdaq | $4.61 | $334.5M | $15.78 | $4.54 | Buy |
The FinQuota filters have identified what they believe to be the "52 Week Low Stocks to Buy (December 21, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.